Literature DB >> 7935413

Topoisomerase II forms multimers in vitro: effects of metals, beta-glycerophosphate, and phosphorylation of its C-terminal domain.

Y S Vassetzky1, Q Dang, P Benedetti, S M Gasser.   

Abstract

We present a novel assay for the study of protein-protein interactions involving DNA topoisomerase II. Under various conditions of incubation we observe that topoisomerase II forms complexes at least tetrameric in size, which can be sedimented by centrifugation through glycerol. The multimers are enzymatically active and can be visualized by electron microscopy. Dephosphorylation of topoisomerase II inhibits its multimerization, which can be restored at least partially by rephosphorylation of multiple sites within its 200 C-terminal amino acids by casein kinase II. Truncation of topoisomerase II just upstream of the major phosphoacceptor sites reduces its aggregation, rendering the truncated enzyme insensitive to either kinase treatments or phosphatase treatments. This is consistent with a model in which interactions involving the phosphorylated C-terminal domain of topoisomerase II aid either in chromosome segregation or in chromosome condensation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7935413      PMCID: PMC359227          DOI: 10.1128/mcb.14.10.6962-6974.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  43 in total

1.  Role of nonhistone proteins in metaphase chromosome structure.

Authors:  K W Adolph; S M Cheng; U K Laemmli
Journal:  Cell       Date:  1977-11       Impact factor: 41.582

2.  The structure of histone-depleted metaphase chromosomes.

Authors:  J R Paulson; U K Laemmli
Journal:  Cell       Date:  1977-11       Impact factor: 41.582

3.  DNA gyrase and its complexes with DNA: direct observation by electron microscopy.

Authors:  T Kirchhausen; J C Wang; S C Harrison
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Organization of the higher-order chromatin loop: specific DNA attachment sites on nuclear scaffold.

Authors:  J Mirkovitch; M E Mirault; U K Laemmli
Journal:  Cell       Date:  1984-11       Impact factor: 41.582

6.  Phosphorylation of DNA topoisomerase II by casein kinase II: modulation of eukaryotic topoisomerase II activity in vitro.

Authors:  P Ackerman; C V Glover; N Osheroff
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

7.  The C-terminal domain of Saccharomyces cerevisiae DNA topoisomerase II.

Authors:  P R Caron; P Watt; J C Wang
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

8.  Higher order metaphase chromosome structure: evidence for metalloprotein interactions.

Authors:  C D Lewis; U K Laemmli
Journal:  Cell       Date:  1982-05       Impact factor: 41.582

9.  Metal ion/buffer interactions. Stability of binary and ternary complexes containing 2-[bis(2-hydroxyethyl)amino]-2(hydroxymethyl)-1,3-propanediol (Bistris) and adenosine 5'-triphosphate (ATP).

Authors:  K H Scheller; T H Abel; P E Polanyi; P K Wenk; B E Fischer; H Sigel
Journal:  Eur J Biochem       Date:  1980-06

10.  Localization of topoisomerase II in mitotic chromosomes.

Authors:  W C Earnshaw; M M Heck
Journal:  J Cell Biol       Date:  1985-05       Impact factor: 10.539

View more
  13 in total

1.  Structure and conformational changes of DNA topoisomerase II visualized by electron microscopy.

Authors:  P Schultz; S Olland; P Oudet; R Hancock
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

Review 2.  A requiem to the nuclear matrix: from a controversial concept to 3D organization of the nucleus.

Authors:  S V Razin; O V Iarovaia; Y S Vassetzky
Journal:  Chromosoma       Date:  2014-03-25       Impact factor: 4.316

3.  Extracellular signal-regulated kinase activates topoisomerase IIalpha through a mechanism independent of phosphorylation.

Authors:  P S Shapiro; A M Whalen; N S Tolwinski; J Wilsbacher; S J Froelich-Ammon; M Garcia; N Osheroff; N G Ahn
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

4.  Active heterodimers are formed from human DNA topoisomerase II alpha and II beta isoforms.

Authors:  H Biersack; S Jensen; I Gromova; I S Nielsen; O Westergaard; A H Andersen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

5.  Increased phosphorylation of DNA topoisomerase II in etoposide resistant mutants of human glioma cell line.

Authors:  Y Matsumoto; K Kunishio; S Nagao
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

6.  A monoclonal antibody against DNA topoisomerase II labels the axial granules of Pleurodeles lampbrush chromosomes.

Authors:  R Hock; M Carl; B Lieb; D Gebauer; U Scheer
Journal:  Chromosoma       Date:  1996       Impact factor: 4.316

7.  Hypersensitivity of Ku-deficient cells toward the DNA topoisomerase II inhibitor ICRF-193 suggests a novel role for Ku antigen during the G2 and M phases of the cell cycle.

Authors:  P Muñoz; M Z Zdzienicka; J M Blanchard; J Piette
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

8.  The three-dimensional structure of in vitro reconstituted Xenopus laevis chromosomes by EM tomography.

Authors:  Peter König; Michael B Braunfeld; John W Sedat; David A Agard
Journal:  Chromosoma       Date:  2007-02-28       Impact factor: 2.919

9.  Chromosomes with two intact axial cores are induced by G2 checkpoint override: evidence that DNA decatenation is not required to template the chromosome structure.

Authors:  P R Andreassen; F B Lacroix; R L Margolis
Journal:  J Cell Biol       Date:  1997-01-13       Impact factor: 10.539

10.  Cell cycle-coupled relocation of types I and II topoisomerases and modulation of catalytic enzyme activities.

Authors:  K N Meyer; E Kjeldsen; T Straub; B R Knudsen; I D Hickson; A Kikuchi; H Kreipe; F Boege
Journal:  J Cell Biol       Date:  1997-02-24       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.